ClinicalTrials.Veeva

Menu

Extracorporeal Carbon Dioxide Removal in Severe Chronic Obstructive Pulmonary Disease Exacerbation

C

China-Japan Friendship Hospital

Status

Unknown

Conditions

COPD Exacerbation

Treatments

Device: Extracorporeal Carbon Dioxide Removal

Study type

Observational

Funder types

Other

Identifiers

NCT03692117
2016YFC1304304-4

Details and patient eligibility

About

The conventional treatment for Severe acute exacerbation of Chronic obstructive pulmonary disease including noninvasive respiratory support, invasive respiratory support, etc, but there are many kinds of limitations and complications. Extracorporeal Carbon Dioxide Removal is a life support technology, which can effectively remove CO2. Recently some clinical studies have showed that ECCO2R can effectively improve the AECOPD patient's respiratory failure, avoid intubation and removal of endotracheal intubation. We performed a study to evaluate the clinical effectiveness of ECCO2R in the treatment of AECOPD patients.

Full description

With the development of technology, ECCO2R is not difficult to implement in intensive care unit. Many recently clinical studies have showed that ECCO2R can effectively remove CO2, reduce patient breathing work, improve the patient respiratory failure, and avoid endotracheal intubation. But there are also treated failure and high incidence of complications such as bleeding in the AECOPD patients with ECCO2R treatment, and the treatment related to airway management are less mentioned. Therefore, we set a more strict inclusion criteria in AECOPD patients and evaluate the clinical effectiveness and associated risk of ECCO2R in the treatment of AECOPD.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NPPV treatment failure:

    1. deterioration or no improvement after treatment with NPPV, pH < 7.25, PaCO2 > 70mmHg
    2. Obvious respiratory distress, RR > 30 times/min
    3. Breathing extreme fatigue

Exclusion criteria

  • Older than 75 years
  • endotracheal intubation or tracheostomy
  • obviously a lot of pus yellow phlegm, expectorate difficult
  • Chest CT: obviously a wide range of consolidation
  • BMI < 20 kg/m2,
  • Dysfunction of other organ of extrapulmonary
  • serious hemodynamic instability
  • severe hypoxemia, PaO2 / FiO2 < 100mmHg
  • home noninvasive positive pressure ventilation for a long time
  • lung fungal infection
  • contraindication of anticoagulation
  • Platelet < 80000 per cubic millimeter
  • Serum creatinine > 200 umol/L
  • cardiac arrest
  • Hospice care
  • Refused to take part in the study

Trial contacts and locations

1

Loading...

Central trial contact

Min Li, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems